seed
Stage
1
Investors
About
Convexia is an AI-driven pharmaceutical platform that uses autonomous software agents to source overlooked preclinical candidates, run computational biology models (e.g., ESM-3, RFdiffusion, AlphaFold) to assess safety and efficacy in silico, and simulate clinical trials and commercial outcomes to advance programs toward Phase 1.
Explore Convexia's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.